KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueDividends payablesLand & ImprovementsLiabilities and Shareholders EquityLoans - NetLoans - NetMinority InterestOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseExpense - Property Taxes and InsuranceExpense - Property and MaintenanceLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredReceivables - NetReceivables - OtherRevenue - Mortgage Backed SecuritiesRevenue - OtherRevenue - RentalShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

National Health Investors (NHI) Receivables - Accured (2023 - 2026)

National Health Investors filings provide 18 years of Revenue - Other readings, the most recent being $42.0 million for Q1 2026.

  • On a quarterly basis, Revenue - Other rose 106.49% to $42.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$18.8 million, a 69.82% increase, with the full-year FY2025 number at $103.8 million, up 35.14% from a year prior.
  • Receivables - Accured hit $221.3 million in Q1 2026 for National Health Investors, up from $154.3 million in the prior quarter.
  • In the past five years, Receivables - Accured ranged from a high of $221.3 million in Q1 2026 to a low of $8.6 million in Q1 2023.
  • Median Receivables - Accured over the past 4 years was $93.4 million (2023), compared with a mean of $87.8 million.
  • The widest YoY moves for Revenue - Other: up 108.12% in 2023, down 75.54% in 2023.
  • National Health Investors' Revenue - Other stood at -$225.9 million in 2022, then surged by 108.12% to $18.3 million in 2023, then rose by 8.88% to $20.0 million in 2024, then soared by 82.95% to $36.5 million in 2025, then grew by 14.9% to $42.0 million in 2026.
  • The last three reported values for Revenue - Other were $42.0 million (Q1 2026), $36.5 million (Q4 2025), and -$41.1 million (Q3 2025) per Business Quant data.